JOSÉ MARÍA
GUINEA DE CASTRO
Pfizer (United States)
Nueva York, Estados UnidosPublications in collaboration with researchers from Pfizer (United States) (1)
2021
-
Cost-effectiveness analysis of gemtuzumab ozogamicin for first-line treatment of patients with cd-33 positive acute myeloid leukaemia in spain
ClinicoEconomics and Outcomes Research, Vol. 13, pp. 263-277